NCT04349553View on ClinicalTrials.gov

Study to Evaluate the Safety, Tolerability and Immunogenicity of a Potential Enteric Fever Vaccine

PHASE1CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

December 16, 2019

Primary Completion Date

September 28, 2020

Study Completion Date

February 15, 2021

Conditions
Enteric Fever
Interventions
BIOLOGICAL

ZH9PA and ZH9

150mL vaccine for oral administration

BIOLOGICAL

Placebo

150mL vaccine for oral administration

BIOLOGICAL

ZH9PA

150mL vaccine for oral administration

Trial Locations (1)

CF48 4DR

Simbec Research, Merthyr Tydfil

All Listed Sponsors
collaborator

Simbec Research

INDUSTRY

lead

Prokarium Ltd

INDUSTRY

NCT04349553 - Study to Evaluate the Safety, Tolerability and Immunogenicity of a Potential Enteric Fever Vaccine | Biotech Hunter | Biotech Hunter